News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
87 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17556)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
A Retrospective Literature Review Published in Pain Management on Prescribing Naloxone for Opioid Overdose Intervention Highlights Opportunities to Expand Community Access to Help Reduce Fatalities
A retrospective literature review, published today in Pain Management, examined prescription naloxone as a harm-reduction strategy and outlined opportunities to expand naloxone use more widely into the community to help reduce opioid overdose fatalities.
April 25, 2018
·
5 min read
Business
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
MaxCyte announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in clinical oncology and pharmaceutical research, as its Chief Medical Officer (CMO).
April 25, 2018
·
3 min read
Drug Development
Alkahest Announces Initiation of Phase 2 Clinical Trial of GRF6019 in Alzheimer’s Disease
Alkahest Inc. announced the initiation of a Phase 2 randomized, double-blinded dose response study of GRF6019 in patients with mild to moderate Alzheimer’s Disease (ALK6019-201).
April 25, 2018
·
2 min read
Drug Development
ConSynance Presents NASH Results
Data on the company’s Phase I nonalcoholic steatohepatitis (NASH) drug candidate, CSTI-100, at NASH Summit 2018, on April 24 in Boston.
April 25, 2018
·
1 min read
Drug Development
Concert Pharmaceuticals Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata
Topline Phase 2a Data from the 4 mg and 8 mg Cohorts Expected in Fourth Quarter of 2018
April 25, 2018
·
5 min read
Pharm Country
The Medicines Company Reports First-Quarter 2018 Results
The Medicines Company today reported its financial results for the first quarter ended March 31, 2018.
April 25, 2018
·
15 min read
BioCapital
Vicky Cornell Partners with Addiction Policy Forum to Launch Lifesaving Resources in Honor of Husband Chris Cornell
Vicky Cornell, wife of Grammy® Award-winning singer and songwriter and Soundgarden, Temple of the Dog and Audioslave front man Chris Cornell, who died unexpectedly last May, announced today the launch of Addiction Resource Center (ARC) For Chris.
April 25, 2018
·
3 min read
Business
410 Medical Strengthens Board of Directors as Company Continues to Accelerate Commercialization of LifeFlow®
410 Medical, Inc. announced it has appointed John Tushar to the 410 Medical Board of Directors.
April 25, 2018
·
1 min read
Pharm Country
Rallybio Established by Industry Leaders with $37.0 Million in Series A Financing to Develop Transformative Therapies for Patients with Severe and Rare Diseases
Rallybio’s focus is on antibodies, small molecules and engineered proteins.
April 25, 2018
·
4 min read
Business
Future Farm and TCG Investments Begin Construction on Two Puerto Rico Medical Marijuana Dispensaries
Future Farm Technologies Inc. is pleased to announce that FFPR LLC is set to begin construction on the first two of five total medical marijuana dispensaries that FFPR plans to open on the island.
April 25, 2018
·
3 min read
Previous
5 of 9
Next